Chemotherapy-induced neurotoxicity (CIN) is a major barrier against optimal anticancer treatment. This study investigated the neuroprotective effects of the naturally occurring antioxidant, Coenzyme Q10 (CoQ10), against CIN using a model of induced pluripotent stem cell (iPSC)-derived neurons. iPSCs have consistently proven to be reliable for disease modeling and drug discovery. We employed cell viability, oxidative stress, and mitochondrial function assays to measure the effect of 10 μM CoQ10 on iPSC-derived motor neuron progenitors (iPSC-MNPs) that were exposed to five chemotherapeutic agents: 5-Fluorouracil, methotrexate, paclitaxel (0, 1, and 10 μM) and doxorubicin, and vincristine (0, 0.1, and 1 μM). Our findings show that CoQ10 significantly reversed the reduction in cell viability inflicted by the exposure of iPSCs-MNPs to all five chemotherapeutics. Moreover, CoQ10 treatment resulted in a marked reduction in intracellular ROS levels and enhancement of mitochondrial membrane potential (MMP) in a drug- and dose-dependent manners, highlighting its role in preserving mitochondrial health. This study is the first to explore the protective effects of CoQ10 against CIN using an iPSC-derived neuronal platform, offering insights into its potential therapeutic use. Further investigation is essential to validate these findings and to determine the behavioral effects of CoQ10 in in vivo models of CIN.
Background: Modified Blair incision is the classical incision for benign parotid lesions, it provides good surgical exposure, but it leaves a visible scar in the neck which bothers a wide range of patients, especially female and young patients. modified facelift incision is the new alternative approach for benign parotid lesions, it cosmetically better than the modified Blair incision because this incision is hidden behind the ear and in the hairline. Materials and Methods:This prospective clinical research comprised 16 individuals who had superficial parotidectomy for benign lesions. Group 1 = 8 patients had a modified facelift incision and Group 2 = 8 had a modified Blair incision. Variables included age, gender, histological diagnosis, operating time, and surgical exposure. The major outcomes were surgical complications and patient satisfaction. Descriptive statistics include mean, median, SD, ranges, frequencies, and proportions. Fisher's exact test compared frequencies, and student's t-test (independent two groups model) compared means P< 0.05 is significant. Results: There were no statistically significant differences in postoperative complications rates between the groups. Of modified blair incisions, 25.0% suffered seroma postoperatively versus12.5 % of modified facelift incisions. Of modified blair incisions, 12.5 % suffered gustatory sweating versus none following modified facelift incisions.